Pubblicazioni

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

2020 - BLOOD CANCER JOURNAL

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

2020 - THE ONCOLOGIST

Ali, S.; Moreau, A.; Melchiorri, D.; Camarero, J.; Josephson, F.; Olimpier, O.; Bergh, J.; Karres, D.; Tzogani, K.; Gisselbrecht, C.; Pignatti, F.

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

2020 - HAEMATOLOGICA

Mauro, F. R.; Molica, S.; Soddu, S.; Ilariucci, F.; Coscia, M.; Zaja, F.; Angelucci, E.; Re, F.; Liberati, A. M.; Tedeschi, A.; Reda, G.; Pietrasanta, D.; Gozzetti, A.; Battistini, R.; Del Poeta, G.; Musolino, C.; Nanni, M.; Piciocchi, A.; Vignetti, M.; Neri, A.; Albano, F.; Cuneo, A.; Giudice, I. D.; Starza, I. D.; de Propris, M. S.; Raponi, S.; Guarini, A. R.; Foa, R.

Cord blood transplantation for acute leukemia

2020 - EXPERT OPINION ON BIOLOGICAL THERAPY

Algeri, M.; Gaspari, S.; Locatelli, F.

Cord blood transplantation for acute leukemia

2020 - EXPERT OPINION ON BIOLOGICAL THERAPY

Algeri, M.; Gaspari, S.; Locatelli, F.